drug
OPUVIZ
Marketedupdated 6mo agoby Samsung Bioepis Co Ltd
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 4all catalysts(4)
News(1)
- Lilly, Foghorn part ways; Wave’s FDA-approved plansThe pharma giant cut its partnership after a cancer drug disappointed in testing. Elsewhere, Teva and Samsung Bioepis expanded a partnership and space biotech Varda brought in $251 million.biopharma_dive · 1mo ago
Data sources
last refreshed 5h ago
Found something off?
comments(0)
5-min edit window · permanent after that